Memorial Sloan Kettering Cancer Center Commack: Clinical Trials at Commack

Browse our continually updated listing of clinical trials available to patients at Memorial Sloan Kettering Cancer Center Commack below. You can also explore our complete listing of clinical trials available at Memorial Sloan Kettering.

Showing 1 - 20 of 107 trials
Title Investigatorsort icon Disease(s)
A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
Newly Diagnosed
[Protocol 11-095]
Zelenetz, Andrew
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154]
Zelefsky, Michael
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112]
Zaider, Talia
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
A Phase I/II Study of Ruxolitinib plus Erlotinib in Patients with Erlotinib-Resistant Lung Adenocarcinoma
[Protocol 14-043]
Yu, Helena
  • Lung Cancer, Non-Small Cell
    • Lung Adenocarcinoma
A Phase III Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094]
Wu, Abraham
  • Upper Gastrointestinal
    • Esophageal Cancer
Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmetic Appearance in Patients with Multiple Tumors in One Breast
[Protocol 13-023]
Van Zee, Kimberly
  • Breast Cancer
A Phase II Study of Exemestane with and without Enzalutamide in Women with Advanced Hormone Receptor-Positive Breast Cancer
[Protocol 13-257]
Traina, Tiffany
  • Breast Cancer
A Phase II Study of Dose-Dense Doxorubicin and Cyclophosphamide followed by Eribulin Mesylate for the Adjuvant Treatment of Early-Stage Breast Cancer
[Protocol 10-190]
Traina, Tiffany
  • Breast Cancer
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women with Ovarian Cancer
[Protocol 11-164]
Tew, William
  • Geriatrics
  • Ovarian Cancer
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
[Protocol 12-104]
Tew, William
  • Geriatrics
  • Ovarian Cancer
A Randomized Phase III Study of Standard Chemotherapy with and without Brentuximab in Patients Newly Diagnosed with Advanced Hodgkin Lymphoma
[Protocol 13-056]
Straus, David
  • Lymphoma
    • Hodgkin's Disease
Examination of Tissue from Ablated Malignant Liver Metastases to Predict Outcome
[Protocol 09-122]
Sofocleous, Constantinos
  • Colorectal Cancer
    • Colon Cancer
  • Liver Metastases
A Phase II Study Comparing Romiplostim with Observation for Chemotherapy-Induced Thrombocytopenia
[Protocol 13-132]
Soff, Gerald
  • Hematology
    • Hematologic Disorders
  • Solid Tumors
A Phase IV Study of Enzalutamide in Men with Metastatic Prostate Cancer Who Are at Risk for Seizures
[Protocol 13-231]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046]
Seidman, Andrew
  • Brain Tumors, Metastatic
  • Breast Cancer
Chemotherapy Alone or with Radiation Therapy for Treating Patients with Locally Advanced Rectal Cancer Undergoing Surgery
[Protocol 12-087]
Saltz, Leonard
  • Colorectal Cancer
    • Rectal Cancer
A Phase II Study of Docetaxel Alone or with OGX-427 in Patients with Recurrent or Refractory Urothelial Cancers
Relapsed/Refractory
[Protocol 13-127]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Study of Gemcitabine and Cisplatin with and without Bevacizumab in Patients with Advanced Transitional Cell Carcinoma
[Protocol 12-119]
Rosenberg, Jonathan
  • Bladder Cancer
  • Kidney Cancer
A Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
[Protocol 11-003]
Rimner, Andreas
  • Lung Cancer
  • Lung Cancer, Small Cell
    • Other